Fundraising FoxBering Capital
Venture capitalActively deployingSan Francisco · Seed–Late Stage · 8 people tracked
Find your way into Bering Capital
Sign up to see every warm intro you have to Bering Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bering Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Bering Capital backs exceptional founders building cutting-edge biotech and medical technology companies, guided by a belief in the importance of great markets aligned with great people. Drawing on lessons learned from early Silicon Valley and venture capital pioneers, as well as its own entrepreneurial experience, the firm focuses on identifying critical problems and acting at the right moment. It emphasizes shaping a company's early DNA to position it for success, aiming to help transform groundbreaking ideas into world-class companies.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & curated & public directories
Managing Partner at Bering Capital, holding MD and PhD credentials.
Managing Partner at Bering Capital.
Advisor to Bering Capital, holding a DPhil.
Advisor to Bering Capital, holding a PhD.
Advisor to Bering Capital, holding an MD.
Advisor to Bering Capital, holding an MD.
Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.
What they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathClinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.
BiotechHouston, US
Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)
BoardSteven Gillis(Director)in
Co-investors3B Future Health FundCanaan PartnersGreatPoint VenturesRiverVest Venture PartnersAlexandriaARCH Venture Partners+5 more
Frequently asked questions
- What stage does Bering Capital invest at?
- Bering Capital invests at the Seed, Series A, Late Stage stages.
- What sectors does Bering Capital focus on?
- Bering Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is Bering Capital located?
- Bering Capital is headquartered in San Francisco, US.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.